Search research articles
Contact Us
Filters
Showing results (411-420 of 449) with videos related to
Page
of 45
Sort By:
Molecular Cancer Research : MCR
|
August 5, 2018
CD38 Inhibits Prostate Cancer Metabolism and Proliferation by Reducing Cellular NAD<sup>+</sup> Pools
Jeffrey P Chmielewski, Sarah C Bowlby, Frances B Wheeler, et al.
Toxicologic Pathology
|
June 28, 2022
Scientific and Regulatory Policy Committee Points to Consider for Medical Device Implant Site Evaluation in Nonclinical Studies
Maureen T O'Brien, JoAnn C L Schuh, Lyn M Wancket, et al.
Bone Marrow Transplantation
|
August 5, 2000
High-dose carmustine, thiotepa and etoposide followed by autologous bone marrow rescue for the treatment of high risk central nervous system tumors
V Papadakis, I J Dunkel, L D Cramer, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 4, 2018
Plasticity in early immune evasion strategies of a bacterial pathogen
Quentin Bernard, Alexis A Smith, Xiuli Yang, et al.
Annals of Emergency Medicine
|
December 5, 2021
Design and Implementation of an Agitation Code Response Team in the Emergency Department
Ambrose H Wong, Jessica M Ray, Laura D Cramer, et al.
The Science of the Total Environment
|
May 2, 2021
Fire and herbivory drive fungal and bacterial communities through distinct above- and belowground mechanisms
M-L Vermeire, J Thoresen, K Lennard, et al.
Toxicologic Pathology
|
December 4, 2023
Scientific and Regulatory Policy Committee Technical Review: Biology and Pathology of Ganglia in Animal Species Used for Nonclinical Safety Testing
Bindu M Bennet, Ingrid D Pardo, Basel T Assaf, et al.
Journal of Medicinal Chemistry
|
September 17, 2009
Identification of N-(5-tert-butyl-isoxazol-3-yl)-N'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea dihydrochloride (AC220), a uniquely potent, selective, and efficacious FMS-like tyrosine kinase-3 (FLT3) inhibitor
Qi Chao, Kelly G Sprankle, Robert M Grotzfeld, et al.
The Prostate
|
January 1, 2009
Association of reported prostate cancer risk alleles with PSA levels among men without a diagnosis of prostate cancer
Fredrik Wiklund, S Lilly Zheng, Jielin Sun, et al.
Journal of the National Cancer Institute
|
July 17, 2003
Association between genetic polymorphisms in the prostate-specific antigen gene promoter and serum prostate-specific antigen levels
Scott D Cramer, Bao-Li Chang, Anuradha Rao, et al.
Page
of 45
Search research articles
Search
Showing results (411-420 of 449) with videos related to
Sort By:
Page
of 45
Molecular Cancer Research : MCR
|
August 5, 2018
CD38 Inhibits Prostate Cancer Metabolism and Proliferation by Reducing Cellular NAD<sup>+</sup> Pools
Jeffrey P Chmielewski, Sarah C Bowlby, Frances B Wheeler, et al.
Toxicologic Pathology
|
June 28, 2022
Scientific and Regulatory Policy Committee Points to Consider for Medical Device Implant Site Evaluation in Nonclinical Studies
Maureen T O'Brien, JoAnn C L Schuh, Lyn M Wancket, et al.
Bone Marrow Transplantation
|
August 5, 2000
High-dose carmustine, thiotepa and etoposide followed by autologous bone marrow rescue for the treatment of high risk central nervous system tumors
V Papadakis, I J Dunkel, L D Cramer, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 4, 2018
Plasticity in early immune evasion strategies of a bacterial pathogen
Quentin Bernard, Alexis A Smith, Xiuli Yang, et al.
Annals of Emergency Medicine
|
December 5, 2021
Design and Implementation of an Agitation Code Response Team in the Emergency Department
Ambrose H Wong, Jessica M Ray, Laura D Cramer, et al.
The Science of the Total Environment
|
May 2, 2021
Fire and herbivory drive fungal and bacterial communities through distinct above- and belowground mechanisms
M-L Vermeire, J Thoresen, K Lennard, et al.
Toxicologic Pathology
|
December 4, 2023
Scientific and Regulatory Policy Committee Technical Review: Biology and Pathology of Ganglia in Animal Species Used for Nonclinical Safety Testing
Bindu M Bennet, Ingrid D Pardo, Basel T Assaf, et al.
Journal of Medicinal Chemistry
|
September 17, 2009
Identification of N-(5-tert-butyl-isoxazol-3-yl)-N'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea dihydrochloride (AC220), a uniquely potent, selective, and efficacious FMS-like tyrosine kinase-3 (FLT3) inhibitor
Qi Chao, Kelly G Sprankle, Robert M Grotzfeld, et al.
The Prostate
|
January 1, 2009
Association of reported prostate cancer risk alleles with PSA levels among men without a diagnosis of prostate cancer
Fredrik Wiklund, S Lilly Zheng, Jielin Sun, et al.
Journal of the National Cancer Institute
|
July 17, 2003
Association between genetic polymorphisms in the prostate-specific antigen gene promoter and serum prostate-specific antigen levels
Scott D Cramer, Bao-Li Chang, Anuradha Rao, et al.
Page
of 45